Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Munder

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|March 15, 2021
Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil GranulocytesVerena Vonwirth, Yagmur Bülbül, Anke Werner, et al.
Plos Neglected Tropical Diseases|July 15, 2009
Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasisManuel Modolell, Beak-San Choi, Robert O Ryan, et al.
Plos Neglected Tropical Diseases|January 26, 2013
Arginase activity in the blood of patients with visceral leishmaniasis and HIV infectionYegnasew Takele, Tamrat Abebe, Teklu Weldegebreal, et al.
Journal of Leukocyte Biology|August 9, 2014
Granulocyte functions are independent of arginine availabilityKatharina Kapp, Steve Prüfer, Christian S Michel, et al.
Blood|November 18, 2004
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activityMarkus Munder, Faustino Mollinedo, Jero Calafat, et al.
Plos Neglected Tropical Diseases|June 22, 2012
Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in EthiopiaTamrat Abebe, Asrat Hailu, Mihretu Woldeyes, et al.
Plos Neglected Tropical Diseases|April 5, 2013
Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopiaTamrat Abebe, Yegnasew Takele, Teklu Weldegebreal, et al.
Journal for Immunotherapy of Cancer|June 11, 2021
Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunityKevin Jan Legscha, Edite Antunes Ferreira, Antonios Chamoun, et al.
European Journal of Immunology|March 3, 2007
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancyPascale Kropf, David Baud, Sara E Marshall, et al.
Leukemia & Lymphoma|November 26, 2021
Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomesLaurent Garderet, Mohammad Al Hariri, Joanna Wasielica-Poslednik, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|March 15, 2021
Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil GranulocytesVerena Vonwirth, Yagmur Bülbül, Anke Werner, et al.
Plos Neglected Tropical Diseases|July 15, 2009
Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasisManuel Modolell, Beak-San Choi, Robert O Ryan, et al.
Plos Neglected Tropical Diseases|January 26, 2013
Arginase activity in the blood of patients with visceral leishmaniasis and HIV infectionYegnasew Takele, Tamrat Abebe, Teklu Weldegebreal, et al.
Journal of Leukocyte Biology|August 9, 2014
Granulocyte functions are independent of arginine availabilityKatharina Kapp, Steve Prüfer, Christian S Michel, et al.
Blood|November 18, 2004
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activityMarkus Munder, Faustino Mollinedo, Jero Calafat, et al.
Plos Neglected Tropical Diseases|June 22, 2012
Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in EthiopiaTamrat Abebe, Asrat Hailu, Mihretu Woldeyes, et al.
Plos Neglected Tropical Diseases|April 5, 2013
Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopiaTamrat Abebe, Yegnasew Takele, Teklu Weldegebreal, et al.
Journal for Immunotherapy of Cancer|June 11, 2021
Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunityKevin Jan Legscha, Edite Antunes Ferreira, Antonios Chamoun, et al.
European Journal of Immunology|March 3, 2007
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancyPascale Kropf, David Baud, Sara E Marshall, et al.
Leukemia & Lymphoma|November 26, 2021
Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomesLaurent Garderet, Mohammad Al Hariri, Joanna Wasielica-Poslednik, et al.
Pageof 9